Managing Pulmonary Arterial Hypertension Across the Medical Neighborhood: Insights for Therapeutic Selection and Care Coordination

Managing Pulmonary Arterial Hypertension Across the Medical Neighborhood: Insights for Therapeutic Selection and Care Coordination

On-Demand Webcast
FACULTY

Richard N. Channick, MD
Director, Pulmonary Hypertention and  
Thromboendarterectomy Program
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School

Megan Santanna, MA, PCMH CCE
Director, Practice Optimization
Ritner Medical Associates
Adjunct Professor
Cabrini University

INTENDED LEARNERS

This activity is intended for professionals devoted to transforming care through the medical home model of care, including clinicians, allied health professionals, practice administrators, quality managers, and consultants. 

LEARNING OBJECTIVES

After completing this activity, participants should be able to:

  • Recognize the clinical and socioeconomic consequences of diagnostic delay and fragmented care in the management of PAH
  • Outline PAH risk factors and diagnostic criteria for the prompt and accurate identification of at-risk and affected patients
  • Evaluate the PAH therapeutic aramentarium for individualized clinical decision-making with respect to mechanisms of action, routes of administration, available efficacy and safety data, and indications
  • Implement management strategies that facilitate coordinated diagnostic, therapeutic, and referral practices across the multidisciplinary care settings of the PAH medical neighborhood
ACTIVITY OVERVIEW

To be eligible for documentation of credit, participants must attend the full activity and submit a completed evaluation form. Participants who complete the evaluation online at within four weeks of the live meeting will immediately receive their documentation of credit.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: November 30, 2018
Expiration Date: November 30, 2019
Estimated time to complete: 45 minutes

For questions regarding this educational activity, please call 609-371-1137.

ACCREDITATION INFORMATION

In support of improving patient care, the National Committee for Quality Assurance (NCQA) is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE) and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for the healthcare team.

CME

NACCME designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PHYSICIAN ASSISTANTS

NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for .75 AAPA Category 1 credit(s). PAs should only claim credit commensurate with the extent of their participation in the activity.

CNE

This continuing nursing education activity awards .75 contact hours.

Provider approved by the California Board of Registered Nursing, Provider #13255 for .75 contact hours.

CPE

This activity is approved for .75 contact hour (.0075 CEU) of continuing pharmacy education (UAN JA0004597-0000-19-007-H04-P).

This educational activity is a knowledge-based activity.

Clinical Reviewer: Peter Oettgen MD, FACC, FAHA, FACP, Preventive Cardiology, Beth Israel Deaconess Medical Center

Nurse Reviewer: Johann Chanin, Senior Consultant, Steadman Group, Denver, CO

PLANNING COMMITTEE

The planning committee comprises Johann Chanin, MSN, RN, PCMH CCE; Richard N. Channick, MD; Peter Oettgen MD, FACC, FAHA, FACP; Megan Santanna, MA, PCMH CCE; Vashon Coehins, Jennifer D'Alessandro, and Bart Ecker, NCQA; and Kristin Ciszeski, Mary Johnson, Michael Kearney, Randy Robbin, and Susan Yarbrough, NACCME.

FINANCIAL DISCLOSURE AND CONFLICTS OF INTEREST

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty reported the following:

Ms. Chanin, Dr. Channick, Dr. Oettgen, and Ms. Santanna have disclosed no relevant financial relationships with any commercial interests.

Ms. Coehins, Ms. D'Alessandro, Mr. Ecker, Ms. Ciszeski, Ms. Johnson, Mr. Kearney, Mr. Robbin, and Ms. Yarbrough have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty have disclosed no off label/unapproved uses of drugs and/or devices will be discussed in the presentations.


HARDWARE/SOFTWARE REQUIREMENTS

The evaluation is accessible after the activity via a PC (Windows 7 or newer) or Mac (Mac OS 10.6 or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

PRIVACY POLICY

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2018 by North American Center for Continuing Medical Education, LLC (NACCME). All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from NACCME. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

GRANT SUPPORT

This educational activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc.